Lazard Asset Management’s Sutro Biopharma STRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Buy |
+10,947
| New | +$7K | ﹤0.01% | 2187 |
|
|
2024
Q4 | – | Sell |
-9,633
| Closed | -$33K | – | 2530 |
|
|
2024
Q3 | $33K | Buy |
+9,633
| New | +$33K | ﹤0.01% | 1970 |
|
|
2024
Q2 | – | Sell |
-16,386
| Closed | -$92K | – | 2424 |
|
|
2024
Q1 | $92K | Buy |
+16,386
| New | +$92K | ﹤0.01% | 1564 |
|
|
2023
Q1 | – | Sell |
-15,868
| Closed | -$128K | – | 2543 |
|
|
2022
Q4 | $128K | Hold |
15,868
| – | – | ﹤0.01% | 1438 |
|
|
2022
Q3 | $88K | Buy |
15,868
+9,014
| +132% | +$50K | ﹤0.01% | 1520 |
|
|
2022
Q2 | $35K | Hold |
6,854
| – | – | ﹤0.01% | 1961 |
|
|
2022
Q1 | $56K | Buy |
+6,854
| New | +$56K | ﹤0.01% | 1689 |
|
|
2021
Q4 | – | Sell |
-2,795
| Closed | -$52K | – | 2453 |
|
|
2021
Q3 | $52K | Buy |
+2,795
| New | +$52K | ﹤0.01% | 1670 |
|